首页 > 市场调查报告书 > 材料

聚合物

市场调查报告书

商品编码

1521396

全球血液相容性聚合物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Blood Compatible Polymers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球血液相容聚合物市场需求预计将从 2023 年的 27.1 亿美元达到 2032 年近 92.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 14.63%。

血液相容性聚合物是专门设计的材料，旨在与血液安全地相互作用，而不会引起不良反应。这些聚合物用于导管、心臟瓣膜和血管移植物等医疗器械。它们的生物相容性确保它们在与血液接触时不会引发凝血、免疫反应或溶血。它们经过精心设计，无毒、抗蛋白质吸附且机械耐用。聚合物科学的进步促进了这些材料的开发，在确保各种血液接触医疗器材的安全性和有效性方面发挥关键作用。

市场动态

血液相容性聚合物市场是由生物医学工程的进步所推动的，旨在提高与血液接触的医疗设备的安全性和有效性。当用于导管、血管移植物和心臟瓣膜等装置时，这些聚合物旨在防止血液凝固（血栓形成）和免疫反应。表面改质技术和聚合物化学的创新使得能够开发模仿自然组织生物相容性的生物材料，从而降低不良反应的风险并提高设备性能。促进病患安全和在医疗器材製造中采用生物相容性材料的监管措施进一步刺激了市场成长。

此外，心血管疾病和慢性肾臟疾病的盛行率不断上升，需要长期使用血液接触装置，这推动了对可靠且耐用的血液相容性聚合物的需求。学术机构、医疗保健提供者和聚合物製造商之间的合作研究旨在解决与医疗设备使用相关的感染控制和血栓栓塞併发症等挑战，促进市场的持续创新。此外，全球医疗保健基础设施投资的增加和医疗保健支出的增加，透过增加采用生物相容性材料的先进医疗和外科手术的可及性，支持市场扩张。然而，开发和生产血液相容性聚合物的高成本可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球血液相容性聚合物市场的各个细分市场进行了包容性评估。血液相容性聚合物产业的成长和趋势为本研究提供了整体方法。

市场区隔

血液相容性聚合物市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

聚氯乙烯
聚四氟乙烯
聚醚砜
聚乙烯
聚醚醚酮
聚砜
聚丙烯

按申请

生物医学和血液接触设备
牙科
药物输送

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲血液相容聚合物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。血液相容性聚合物市场的主要参与者包括AdvanSource Biomaterials Corporation、Sanofi SA、Baxter International Inc.、ASM International、Biomaterial USA LLC.、Eastman Chemical Company、Evonik Industries AG、The Dow Chemical Company、江苏Senolo 医疗科技有限公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：血液相容性聚合物公司的竞争格局

血液相容性聚合物市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
AdvanSource Biomaterials Corporation

公司简介
公司收入
产品
最近的发展

Sanofi SA

公司简介
公司收入
产品
最近的发展

Baxter International Inc.

公司简介
公司收入
产品
最近的发展

ASM International

公司简介
公司收入
产品
最近的发展

Biomaterial USA LLC.

公司简介
公司收入
产品
最近的发展

Eastman Chemical Company

公司简介
公司收入
产品
最近的发展

Evonik Industries AG

公司简介
公司收入
产品
最近的发展

The Dow Chemical Company

公司简介
公司收入
产品
最近的发展

Jiangsu Senolo Medical Technology Co Ltd.

公司简介
公司收入
产品
最近的发展

TOPAS Advanced Polymers Gmbh

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115221

The global demand for Blood Compatible Polymers Market is presumed to reach the market size of nearly USD 9.27 Billion by 2032 from USD 2.71 Billion in 2023 with a CAGR of 14.63% under the study period 2024-2032.

Blood-compatible polymers are specialized materials designed to interact safely with blood without causing adverse reactions. These polymers are used in medical devices like catheters, heart valves, and vascular grafts. Their biocompatibility ensures they do not trigger clotting, immune responses, or hemolysis when in contact with blood. They are engineered to be nontoxic, resistant to protein adsorption, and mechanically durable. Advances in polymer science enable the development of these materials, which play a critical role in ensuring the safety and efficacy of various blood-contacting medical devices.

MARKET DYNAMICS

The market for blood compatible polymers is driven by advancements in biomedical engineering aimed at improving the safety & efficacy of medical devices that come into contact with blood. When used in devices such as catheters, vascular grafts, and heart valves, these polymers are designed to prevent blood clotting (thrombosis) and immune reactions. Innovations in surface modification techniques and polymer chemistry enable the development of biomaterials that mimic the biocompatibility of natural tissues, reducing the risk of adverse reactions and enhancing device performance. Regulatory initiatives promoting patient safety and the adoption of biocompatible materials in medical device manufacturing further stimulate market growth.

Additionally, the rising prevalence of cardiovascular diseases & chronic kidney disorders necessitating prolonged use of blood-contacting devices drives demand for reliable and durable blood compatible polymers. Collaborative research efforts between academic institutions, healthcare providers, and polymer manufacturers aim to address challenges such as infection control and thromboembolic complications associated with medical device use, fostering continuous innovation in the market. Moreover, growing investments in healthcare infrastructure and rising healthcare expenditure globally support market expansion by increasing accessibility to advanced medical treatments and surgical interventions employing biocompatible materials. However, the high cost of developing and producing blood compatible polymers may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Compatible Polymers. The growth and trends of Blood Compatible Polymers industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood Compatible Polymers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Polyvinylchloride
Polytetrafluoroethylene
Polyethersulfone
Polyethylene
Polyetheretherketone
Polysulfone
Polypropylene

By Application

Biomedical & Blood Contacting Devices
Dental
Drug Delivery

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood Compatible Polymers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Compatible Polymers market include AdvanSource Biomaterials Corporation, Sanofi S.A., Baxter International Inc., ASM International, Biomaterial USA LLC., Eastman Chemical Company, Evonik Industries AG, The Dow Chemical Company, Jiangsu Senolo Medical Technology Co Ltd., TOPAS Advanced Polymers Gmbh. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BLOOD COMPATIBLE POLYMERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Polyvinylchloride Historic and Forecast Sales By Regions
5.4. Polytetrafluoroethylene Historic and Forecast Sales By Regions
5.5. Polyethersulfone Historic and Forecast Sales By Regions
5.6. Polyethylene Historic and Forecast Sales By Regions
5.7. Polyetheretherketone Historic and Forecast Sales By Regions
5.8. Polysulfone Historic and Forecast Sales By Regions
5.9. Polypropylene Historic and Forecast Sales By Regions

6. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Biomedical & Blood Contacting Devices Historic and Forecast Sales By Regions
6.4. Dental Historic and Forecast Sales By Regions
6.5. Drug Delivery Historic and Forecast Sales By Regions

7. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE BLOOD COMPATIBLE POLYMERS COMPANIES

8.1. Blood Compatible Polymers Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF BLOOD COMPATIBLE POLYMERS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. AdvanSource Biomaterials Corporation
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Sanofi S.A.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Baxter International Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. ASM International
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Biomaterial USA LLC.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Eastman Chemical Company
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Evonik Industries AG
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. The Dow Chemical Company
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Jiangsu Senolo Medical Technology Co Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. TOPAS Advanced Polymers Gmbh
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments